Your browser doesn't support javascript.
loading
Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate.
Kong, Fan-En; Li, Guang-Meng; Tang, Yun-Qiang; Xi, Shao-Yan; Loong, Jane Ho Chun; Li, Mei-Mei; Li, Hao-Long; Cheng, Wei; Zhu, Wen-Jie; Mo, Jia-Qiang; Gong, Yuan-Feng; Tang, Hui; Zhao, Yue; Zhang, Yan; Ma, Stephanie; Guan, Xin-Yuan; Ma, Ning-Fang; Xie, Mao-Bin; Liu, Ming.
Afiliación
  • Kong FE; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Li GM; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou 511436, China.
  • Tang YQ; The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People's Hospital, Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
  • Xi SY; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Loong JHC; State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
  • Li MM; School of Biomedical Sciences, State Key Laboratory of Liver Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong 852, Hong Kong.
  • Li HL; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Cheng W; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou 511436, China.
  • Zhu WJ; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Mo JQ; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou 511436, China.
  • Gong YF; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Tang H; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou 511436, China.
  • Zhao Y; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Zhang Y; Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, School of Basic Medical Science, Guangzhou Medical University, Guangzhou 511436, China.
  • Ma S; Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China.
  • Guan XY; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Ma NF; Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou 510095, China.
  • Xie MB; General, Visceral and Cancer Surgery, University Hospital of Cologne, Cologne 50923, Germany.
  • Liu M; Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, China.
Sci Transl Med ; 13(579)2021 02 03.
Article en En | MEDLINE | ID: mdl-33536280

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Inmunoconjugados / Neoplasias Hepáticas / Antineoplásicos Límite: Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Inmunoconjugados / Neoplasias Hepáticas / Antineoplásicos Límite: Humans Idioma: En Revista: Sci Transl Med Asunto de la revista: CIENCIA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: China